Literature DB >> 8896173

HLA-DPA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) and distribution of DPA1 alleles in Caucasian, African and Oriental populations.

A Aldener-Cannavá1, O Olerup.   

Abstract

In the present study PCR primers were designed for detecting all known DPA1 variability, i.e., the presently recognized six DPA1 alleles 0103 to 0401, and also for separation of the four DPA1*02 alleles, by PCR amplification with sequence-specific primers (PCR-SSP). For each sample seven different PCR reactions were performed which allowed the identification of all DPA1 alleles and the resolution of all DPA1 genotypes. Forty-eight cell lines and 100 donor spleen cells were investigated by the DPA1 PCR-SSP technique. In the forty-eight known workshop cell-lines no false positive or false negative results were obtained. The 100 donor spleen cells were only typed by the PCR-SSP technique and in their DNAs only one or two DPA1 alleles were found. Twenty cell lines and twenty donor spleen cells were typed on two separate occasions and interpreted blindly. The reproducibility between the repeated typings was 100%. The length of the specific products ranged from 103 to 258 base pairs and the amplification patterns obtained were easy to interpret. In conclusion, DPA1 typing by the PCR-SSP method is an accurate typing technique with high sensitivity, specificity and reproducibility. Analysis of the distribution of DPA1 alleles was performed in 100 Caucasian samples, 100 African samples and 80 Oriental samples, including separation of the four of HLA-DPA1 alleles. Each ethnic group appeared to have one (Caucasians), or two (Africans and Orientals), frequent DPA1 allele(s) and a high frequency of DPA1 homozygotes, suggesting that, like for the DPB1 locus, balancing selection does not appear to be affecting the evolution of the DPA1 locus.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8896173     DOI: 10.1111/j.1399-0039.1996.tb02623.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  6 in total

1.  Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies.

Authors:  Owen D Solberg; Steven J Mack; Alex K Lancaster; Richard M Single; Yingssu Tsai; Alicia Sanchez-Mazas; Glenys Thomson
Journal:  Hum Immunol       Date:  2008-06-09       Impact factor: 2.850

2.  Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis.

Authors:  L Padyukov; J Lampa; M Heimbürger; S Ernestam; T Cederholm; I Lundkvist; P Andersson; Y Hermansson; A Harju; L Klareskog; J Bratt
Journal:  Ann Rheum Dis       Date:  2003-06       Impact factor: 19.103

3.  Extreme high prevalence of a defective mannose-binding lectin (MBL2) genotype in native South American West Andean populations.

Authors:  José Raul Sandoval; Hans O Madsen; Gianfranco De Stefano; Jaime Descailleaux-Dulanto; Margarita Velazquez-Reinoso; Cesar Ñique; Ricardo Fujita; Peter Garred
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

4.  Non-HLA genes PTPN22, CDK6 and PADI4 are associated with specific autoantibodies in HLA-defined subgroups of rheumatoid arthritis.

Authors:  Omri Snir; David Gomez-Cabrero; Ariana Montes; Eva Perez-Pampin; Juan J Gómez-Reino; Maria Seddighzadeh; Katharina U Klich; Lena Israelsson; Bo Ding; Anca I Catrina; Rikard Holmdahl; Lars Alfredsson; Lars Klareskog; Jesper Tegnér; Antonio Gonzalez; Vivianne Malmström; Leonid Padyukov
Journal:  Arthritis Res Ther       Date:  2014-08-20       Impact factor: 5.156

5.  First report on HLA-DPA1 gene allelic distribution in the general Lebanese population.

Authors:  Joseph Haddad; Dina Shammaa; Fatmeh Abbas; Rami A R Mahfouz
Journal:  Meta Gene       Date:  2016-01-21

6.  Effect of HLA-DPA1 alleles on chronic hepatitis B prognosis and treatment response.

Authors:  Seyma Katrinli; Feruze Yilmaz Enc; Kamil Ozdil; Oguzhan Ozturk; Ilyas Tuncer; Gizem Dinler Doganay; Levent Doganay
Journal:  North Clin Istanb       Date:  2017-01-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.